Group sequential and adaptive designs - a review of basic concepts and points of discussion.
In recent times, group sequential and adaptive designs for clinical trials have attracted great attention from industry, academia and regulatory authorities. These designs allow analyses on accumulating data - as opposed to classical, "fixed-sample" statistics. The rapid development of a great variety of statistical procedures is accompanied by a lively debate on their potential merits and shortcomings. The purpose of this review article is to ease orientation in both respects. First, we provide a concise overview of the essential technical concepts, with special emphasis on their interrelationships. Second, we give a structured review of the current controversial discussion on practical issues, opportunities and challenges of these new designs.
Vandemeulebroecke
Marc
M
Novartis Pharma AG, Novartis Campus, 4056 Basel, Switzerland. marc.vandemeulebroecke@novartis.com
D000465:Algorithms; D002986:Clinical Trials as Topic / Q000379:methods / Q000706:statistics & numerical data*; D006801:Humans; D015233:Models, Statistical; D015203:Reproducibility of Results